
With a record number of overdose deaths, Alberta moves to end access to legal injectable opioids
Patients who use the therapy are suing the Alberta government for ending a program that serves injectable synthetic opioids to people who are severely...
When Susan Tierney’s son Keigan was living on the streets and in the grips of a severe opioid addiction, she would spend her nights waiting for her phone to ring, hoping to hear his voice.
“We asked him to call us once a week just so we would know he was alive, and we wouldn’t hear from him for weeks at a time,” the mother of two said from her home in Calgary.
“I can’t even explain what that feeling is like. And I would not have been a fan of or a supporter of a harm reduction program until we saw what it did for our son.”
The program that helped Keigan, 27, turn his life around was Alberta’s Injectable Opioid Agonist Therapy program, known as iOAT. It provides injectable synthetic opioids three times a day to patients in a clinical supervised setting.
The program was established by Alberta’s previous government in 2019 and includes one clinic in Edmonton and one in Calgary. It targets individuals who have been using opioids intravenously for years, sometimes decades, and requires them to have failed at least two other previous treatments or to prove that they’ve been unable to access effective treatment at all.
The provincial government has decided it won’t continue to fund the program after March 2021.